JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Activity Details

245 * Mon, 7/30/2012, 2:00 PM - 3:50 PM CC-Room 23B
Planning and Analysis of Noninferiority Studies — Contributed Papers
Biopharmaceutical Section
Chair(s): Mary Almas, Pfizer Inc.
2:05 PM Sample Size Consideration in Noninferiority Designs Chengxing Lu, Novartis ; Xing Sun, Merck
2:20 PM The Stochastic Curtailment of Long-Term Clinical Trials for Noninferiority Case vs. Superiority Case and Its Visualization Shaoyi Li, Celgene Corporation
2:35 PM Estimating the Effect Size of Approved Drugs for the Treatment of Bacterial Conjunctivitis Studies Yan Wang, FDA/CDER/OTS/OB ; Yunfan Deng, FDA/CDER/OTS/OB ; Daphne Lin, FDA ; Jennifer Harris, FDA/CDER/OND/OAP/DTOP
2:50 PM A Simple Approach in Determining Sample Size and Power for Assessing Noninferiority of a Test Treatment When There Is a Placebo Jerry Weaver, Novartis
3:05 PM Inferiority Index and the Behrens-Fisher Problem for Noninferiority Trials George Y.H. Chi, Janssen Pharmaceuticals R&D
3:20 PM Comparisons of Noninferiority Methods When the Control Group Rate Is Low (= 10%) Alison Pedley, Merck ; Joseph Massaro, Boston University ; Robert W. Tipping, Merck
3:35 PM The Issue of Multiplicity in Noninferiority Studies Chunlei Ke, Amgen, Inc. ; Beiying Ding, Amgen, Inc. ; Qi Jiang, Amgen, Inc. ; Steven Michael Snapinn, Amgen, Inc.

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.